Results 221 to 230 of about 49,191 (297)
ABSTRACT Aim The aim of this Phase I/II open‐label study was to assess the safety and efficacy of NTI164, a novel full‐spectrum medicinal cannabis plant extract 0.08% Δ‐9‐tetrahydrocannabinol (THC), in Rett syndrome (RTT). Methods Eleven female participants (5–16 years) with a pathogenic variant in the MECP2 gene were recruited to this study, receiving
B. A. Keating +7 more
wiley +1 more source
Dermatologists' knowledge, attitudes, and practices regarding omalizumab therapy for chronic urticaria. [PDF]
Wu S, Ye X, Liu X, Dai L, Chen H.
europepmc +1 more source
Abstract This study investigates how pre‐service L2 English teachers manage turn allocation when student willingness to participate is uncertain or absent during microteaching sessions. Drawing on conversation analysis (CA), we examine video‐recorded teaching demonstrations conducted by undergraduate L2 English education majors in South Korea.
Eunseok Ro, Hyunwoo Kim
wiley +1 more source
Sexual Dysfunction in Chronic Urticaria: A Systematic Review. [PDF]
Park SE +6 more
europepmc +1 more source
ABSTRACT Digitalization of the labour process has occasioned the emergence of new temporal orders at work. For newspaper journalists, it has resulted in a radical reorganization of newsrooms and the temporalities of news production, offering a key site for studying this process of temporal reordering.
Xanthe Whittaker
wiley +1 more source
Sleep Disturbance Mediates the Association Between Disease Activity and Work Productivity Impairments in Chronic Urticaria. [PDF]
Mak HWF, Lee E, Wong JCY, Li PH.
europepmc +1 more source
Dupilumab improves quality of life assessed by the Quality of Life in Hand Eczema Questionnaire
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Eric L. Simpson +10 more
wiley +1 more source
Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review
ABSTRACT We report an 11‐month‐old boy with diffuse cutaneous mastocytosis whose severe pruritus and steroid dependence resolved following off‐label treatment with omalizumab. A literature review identified five additional pediatric cases in which omalizumab led to complete symptom resolution in an average of 2 months and permitted discontinuation of ...
Janis Chang +3 more
wiley +1 more source
Acceptance and perceived usefulness of digital health services in the management of chronic urticaria: a survey of patients and physicians. [PDF]
Hindelang M +7 more
europepmc +1 more source

